Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency.
Bénit, Paule
Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency. [electronic resource] - EBioMedicine Mar 2017 - 75-87 p. digital
Publication Type: Journal Article
2352-3964
10.1016/j.ebiom.2017.02.013 doi
Animals
Apoptosis Inducing Factor--deficiency
Cells, Cultured
Cerebellum--metabolism
Female
Fibroblasts--metabolism
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)--metabolism
Glycolysis
Humans
Hypoglycemic Agents--pharmacology
Male
Mice
Mitochondria--drug effects
Mitochondrial Encephalomyopathies--drug therapy
Muscle, Skeletal--metabolism
Pioglitazone
Thiazolidinediones--pharmacology
Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency. [electronic resource] - EBioMedicine Mar 2017 - 75-87 p. digital
Publication Type: Journal Article
2352-3964
10.1016/j.ebiom.2017.02.013 doi
Animals
Apoptosis Inducing Factor--deficiency
Cells, Cultured
Cerebellum--metabolism
Female
Fibroblasts--metabolism
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+)--metabolism
Glycolysis
Humans
Hypoglycemic Agents--pharmacology
Male
Mice
Mitochondria--drug effects
Mitochondrial Encephalomyopathies--drug therapy
Muscle, Skeletal--metabolism
Pioglitazone
Thiazolidinediones--pharmacology